Vertex Pharmaceuticals Incorporated vs Zeta Global Holdings Corp — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.09 (market cap $121.95B), while Zeta Global Holdings Corp trades at $21.12 (market cap $5.32B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 22.9× Zeta Global Holdings Corp's market cap. Which is the better fit depends on your goals.
| VRTX | ZETA | |
|---|---|---|
Market Cap | $121.95B | $5.32B |
Sector | Health | Technology |
52-Week High | $529.59 | $25.24 |
52-Week Low | $366.54 | $14.55 |
Enterprise Value | $116.69B | $5.23B |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →